Drug Characteristics
  • Formulation

    400 mg tablets

  • Dose

    400 mg twice daily in adults

  • Side Effects

    Rash and GI side affects are the most common but generally well tolerated

  • Interactions

    Uncommon. Please refer to the University of Liverpool HIV drug interactions website or app.

  • Renal

    No dose alterations required

  • Hepatic

    No information available on use in severe hepatic impairment

  • Pregnancy

    Manufacturer advises avoid but please refer to the pregnancy guidelines for indications on when  to use raltegravir

  • Other Information

    Preferred regimen in HIV post-exposure prophylaxis